SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-028681
Filing Date
2013-05-14
Accepted
2013-05-14 16:06:24
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v343698_10q.htm 10-Q 249533
2 EXHIBIT 10.1 v343698_ex10-1.htm EX-10.1 97568
3 EXHIBIT 10.2 v343698_ex10-2.htm EX-10.2 16689
4 EXHIBIT 31.1 v343698_ex31-1.htm EX-31.1 9926
5 EXHIBIT 31.2 v343698_ex31-2.htm EX-31.2 9764
6 EXHIBIT 32.1 v343698_ex32-1.htm EX-32.1 4184
  Complete submission text file 0001144204-13-028681.txt   3105370

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT iliu-20130331.xml EX-101.INS 279545
8 XBRL TAXONOMY EXTENSION SCHEMA iliu-20130331.xsd EX-101.SCH 41343
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20130331_cal.xml EX-101.CAL 30417
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20130331_def.xml EX-101.DEF 198346
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20130331_lab.xml EX-101.LAB 371975
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20130331_pre.xml EX-101.PRE 237765
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 13841569
SIC: 2835 In Vitro & In Vivo Diagnostic Substances